论文部分内容阅读
数种核苷酸类似物被用于抗慢生HBV感染获一定疗效后,拉米夫定似乎是最有效的。对拉米夫定的观察集中在核苷酸代谢和拉米夫定的分子作用以及临床研究结果上。该作者报道了用拉米夫定治疗慢性HBV感染的试验结果,报道了肝局部移植术前或术后HBV再感染的治疗和在免疫抑制下的慢性HB
Lamivudine appears to be the most potent after several nucleotide analogues have been used to treat chronic HBV infection. Observations of lamivudine have focused on nucleotide metabolism and the molecular effects of lamivudine as well as on the clinical findings. The authors report the results of a trial of lamivudine in the treatment of chronic HBV infection and report the treatment of HBV reinfection in pretransplant or postoperative liver transplantation and chronic immunosuppression